Related Experiment Video
Updated: May 31, 2026
04:09
Minimal Invasive Resection of Large Retrosternal Thyroid Goiter
Published on: September 20, 2024
A giant euthyroid endemic multinodular goiter with no obstructive or compressive symptoms.
Ahmed Nada1, Ashraf Mohamed Ahmed, Ramon Vilallonga
1General Surgery Department, Cairo University, 28 Mourad street, Giza, Egypt.
Case Reports in Medicine
|July 1, 2011
Summary
This case report details the surgical removal of a record-breaking 4.7kg thyroid goiter. Early intervention is crucial for managing large thyroid glands and preventing respiratory compromise.
Area of Science:
- Endocrinology
- Surgical Oncology
Background:
- Diffusely enlarged thyroid glands (goitres), while less common, persist in certain regions, potentially causing compressive symptoms affecting the trachea, esophagus, and recurrent laryngeal nerve.
- Surgical management of large goitres demands significant expertise due to the risk of severe complications.
Observation:
- A case of a 61-year-old female patient with an extremely enlarged thyroid gland is presented.
- The patient underwent surgical thyroidectomy, with the excised specimen weighing an unprecedented 4.7 kg (10.4 lbs).
- Histopathological analysis revealed a multinodular goitre characterized by multiple cysts, hemorrhage, and necrosis.
Findings:
- The surgical excision successfully resolved the patient's compressive symptoms.
- The reported thyroid specimen represents the largest ever documented in medical literature.
Implications:
- Surgical intervention is effective in immediately alleviating local symptoms associated with large goitres, particularly when substernal extension is present.
- Prompt treatment of thyroid goitres before substernal involvement is recommended to mitigate risks of respiratory compromise.
- Management of exceptionally large thyroid goitres should be exclusively undertaken by highly experienced surgeons.
Related Concept Videos
01:27Goiter
Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...